ArticleIN VIVO ASSESSMENT OF ROSUVASTATIN EFFICACY ON EXPERIMENTAL MURINE WITH AVIRULENT TOXOPLASMOSIS
ArticleIN VIVO ASSESSMENT OF ROSUVASTATIN EFFICACY ON EXPERIMENTAL MURINE WITH AVIRULENT TOXOPLASMOSIS
ArticleASSESMENT OF THE THERAPUTIC EFECT OF LATE AZITHROMYCIN TREATMENT ON CHRONIC MURINE TOXOPLASMOSIS
ArticleASSESMENT OF THE THERAPUTIC EFECT OF LATE AZITHROMYCIN TREATMENT ON CHRONIC MURINE TOXOPLASMOSIS
ArticleTHE EFFECT OF CLINDAMYCIN AND SULFADIAZINE ON EXPERIMENTAL MURINE MODEL WITH ACUTE TOXOPLASMOSIS
ArticleTHE EFFECT OF CLINDAMYCIN AND SULFADIAZINE ON EXPERIMENTAL MURINE MODEL WITH ACUTE TOXOPLASMOSIS
ArticleASSESSMENT THE IMPACT OF THE USE OF POLYMER NPs IN TREATMENT OF EXPERIMENTAL MURINE TOXOPLASMOSIS
ArticleASSESSMENT THE IMPACT OF THE USE OF POLYMER NPs IN TREATMENT OF EXPERIMENTAL MURINE TOXOPLASMOSIS
ArticlePROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS
ArticlePROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS
ArticlePOTENTIAL PROPHYLACTIC EFFECT OF ORAL VERSUS INTRAARTICULAR ATORVASTATIN IN EXPERIMENTAL MODEL OF OSTEOARTHRITIS
ArticlePOTENTIAL PROPHYLACTIC EFFECT OF ORAL VERSUS INTRAARTICULAR ATORVASTATIN IN EXPERIMENTAL MODEL OF OSTEOARTHRITIS
ArticleTHERAPEUTIC EFFICACY OF RESIQUIMOD ON TREATING CHRONIC TOXOPLASMOSIS IN EXPERIMENTAL INFECTED MICE
ArticleTHERAPEUTIC EFFICACY OF RESIQUIMOD ON TREATING CHRONIC TOXOPLASMOSIS IN EXPERIMENTAL INFECTED MICE